4basebio PLC (AIM:4BB)
London
· Delayed Price · Currency is GBP · Price in GBX 712.50
0.00 (0.00%)
At close: Dec 5, 2025
4basebio Market Cap
4basebio has a market cap or net worth of 110.28 million as of December 5, 2025. Its market cap has decreased by -33.76% in one year.
Market Cap
110.28M
Enterprise Value
99.60M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
712.50
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 41.57M to 110.28M, an increase of 165.27%. That is a compound annual growth rate of 22.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 110.28M | -28.83% |
| Dec 31, 2024 | 154.94M | 84.96% |
| Dec 29, 2023 | 83.77M | -4.21% |
| Dec 30, 2022 | 87.45M | 15.45% |
| Dec 31, 2021 | 75.75M | 82.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.00B |
| GSK plc | 73.57B |
| Haleon | 32.85B |
| Smith & Nephew | 10.46B |
| Convatec Group | 4.54B |
| Hikma Pharmaceuticals | 3.49B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.73B |